Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Michael C.
United States
USD 50 /hr
Biotechnologist with 10+ years experience in bioprocess improvement & method development and antibody drug conjugates
Profile Summary
Subject Matter Expertise
Services
Research
Feasibility Study,
Technology Scouting,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Big Data Analytics
Product Development
Formulation,
Stability/Shelf Life Testing,
Product Evaluation,
Material Sourcing,
Product Validation,
Concept Development,
Prototyping
Work Experience
Scientists
Avitide, LLC
December 2020 - Present
Olympus Biotech
2011 - August 2013
Research Biologist
Glycofi Inc
August 2004 - December 2010
Agilix Corp
2002 - 2004
Cornell University
1996 - 1997
Education
PhD (Chemistry)
Dartmouth College
August 2013 - Present
M.S. (Cell Biology)
Yale University
July 1997 - August 2002
A.B. (Biochemistry)
Cornell University
August 1992 - May 1996
Certifications
- Certification details not provided.
Publications
CONFERENCE POSTER
Michael Cukan(2020). KPMW135, a Biosuperior CD3 Bispecific Version of Rituximab Created By a Novel Chemical Conjugation Technology Demonstrates Increased Anti-Tumor Activity By Adding T Cell-Mediated Cytotoxicity Activity to the Existing Mechanisms of Rituximab . Blood. 136. (Supplement 1). p. 9--10. American Society of Hematology
Michael Cukan(2020). 635 A novel site-directed chemical conjugation technology confers antitumor activity via native Fc receptor to plasma immunoglobulin by attaching tumor binders . Regular and young investigator award abstracts. {BMJ} Publishing Group Ltd
JOURNAL ARTICLE
Cukan, Michael C. and Hopkins, Daniel and Burnina, Irina and Button, Michelle and Giaccone, Erin and Houston-Cummings, Nga Rewa and Jiang, Youwei and Li, Fang and Mallem, Muralidhar and Mitchell, Teresa and et al.(2012). Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris . Journal of Immunological Methods. 386. (1-2). p. 34-42. Elsevier
Zhang, Ningyan and Liu, Liming and Dan Dumitru, Calin and Cummings, Nga Rewa Houston and Cukan, Michael and Jiang, Youwei and Li, Yuan and Li, Fang and Mitchell, Teresa and Mallem, Muralidhar R. and et al.(2011). Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study . mAbs. 3. (3). p. 289-298. Landes Bioscience
Jiang, Youwei and Li, Fang and Zha, Dongxing and Potgieter, Thomas I. and Mitchell, Teresa and Moore, Renée and Cukan, Michael and Houston-Cummings, Nga Rewa and Nylen, Adam and Drummond, James E. and et al.(2011). Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris . Protein Expression and Purification. 76. (1). p. 7-14. Elsevier
Jiang, Youwei and Li, Fang and Button, Michelle and Cukan, Michael and Moore, Renee and Sharkey, Nathan and Li, Huijuan(2010). A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris . Protein Expression and Purification. 74. (1). p. 9-15. Elsevier
An, Zhiqiang and Forrest, Gail and Moore, Renee and Cukan, Michael and Haytko, Peter and Huang, Lingyi and Vitelli, Salvatore and Zhao, Jing Zhang and Lu, Ping and Hua, Jin and et al.(2009). IgG2m4, an engineered antibody isotype with reduced Fc function . mAbs. 1. (6). p. 572-579. Landes Bioscience
Potgieter, Thomas I. and Cukan, Michael and Drummond, James E. and Houston-Cummings, Nga Rewa and Jiang, Youwei and Li, Fang and Lynaugh, Heather and Mallem, Muralidhar and McKelvey, Troy W. and Mitchell, Teresa and et al.(2009). Production of monoclonal antibodies by glycoengineered Pichia pastoris . Journal of Biotechnology. 139. (4). p. 318-325. Elsevier
Choi, Byung-Kwon and Actor, Jeffrey K. and Rios, Sandra and dâAnjou, Marc and Stadheim, Terrance A. and Warburton, Shannon and Giaccone, Erin and Cukan, Michael and Li, Huijuan and Kull, Angela and et al.(2008). Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response . Glycoconjugate Journal. 25. (6). p. 581-593. Springer-Verlag
Li, Huijuan and Sethuraman, Natarajan and Stadheim, Terrance A and Zha, Dongxing and Prinz, Bianka and Ballew, Nicole and Bobrowicz, Piotr and Choi, Byung-Kwon and Cook, W James and Cukan, Michael and et al.(2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris . Nature Biotechnology. 24. (2). p. 210-215. Nature Publishing Group
OTHER
Gong, Bing and Cukan, Michael and Fisher, Richard and Li, Huijuan and Stadheim, Terrance A. and Gerngross, Tillman(2009). Characterization of N-Linked Glycosylation on Recombinant Glycoproteins Produced in Pichia pastoris Using ESI-MS and MALDI-TOF . 213-223Springer-Verlag